Researchers have shown, for the first time, how the genetic material of the Nipah virus replicates in infected cells. The ...

As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...

The replication of the Nipah virus's genetic material in infected cells has been demonstrated for the first time by ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

New research into how a retrovirus is spreading across populations of wild koalas in Queensland, Australia is leading to a ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

Discovered in the state of Ceará, Brazil, the novel coronavirus shares similarities with the virus responsible for Middle ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid ...